Skip to main content
Terug
Watch Compare

Harvard Apparatus Regenerative Technology, Inc.

Datakwaliteit: 100%
HRGN
OTC Manufacturing Measuring & Analyzing Instruments
€ 1,57
▼ € 0,11 (-6,26%)
Marktkapitalisatie: 27,64 M
Prijs
€ 1,57
Marktkapitalisatie
27,64 M
Dagbereik
€ 1,48 — € 1,48
52-Weeksbereik
€ 0,94 — € 2,22
Volume
2
Openen € 1,48
50D / 200D Gem.
€ 1,73
8,94% below
50D / 200D Gem.
€ 1,74
9,47% below

Quick Summary

Belangrijkste Punten

Negative free cash flow of -3,83 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)63,72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-593,43%
Onder sectorgemiddelde (-51,02%)
ROIC-424,13%
Net Margin-975,71%
Op. Margin-982,24%

Veiligheid

Debt / Equity
N/A
Current Ratio1,86
Interest Coverage-864,38

Waardering

PE (TTM)
-4,02
Onder sectorgemiddelde (-1,98)
P/B Ratio17,78
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (44 peers)
Metriek Aandeel Sector Mediaan
P/E -4,0 -2,0
P/B 17,8 5,1
ROE % -593,4 -51,0
Net Margin % -975,7 -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 63,72% Revenue Growth (3Y) 161,44%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 704.000,0 Net Income (TTM) -6,87 M
ROE -593,43% ROA -293,36%
Gross Margin N/A Operating Margin -982,24%
Net Margin -975,71% Free Cash Flow (TTM) -3,83 M
ROIC -424,13% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,86
Interest Coverage -864,38 Asset Turnover 0,30
Working Capital 751.000 Tangible Book Value 1,55 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,02 Forward P/E N/A
P/B Ratio 17,78 P/S Ratio 39,26
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -13,85%
Market Cap 27,64 M Enterprise Value 26,32 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,04
FCF / Share -0,22 OCF / Share -0,22
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 55,73%
SBC-Adj. FCF -5,91 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 704.000,0 430.000,0 103.000,0 — 0,0
Net Income -6,87 M -7,73 M -8,95 M -6,07 M -7,98 M
EPS (Diluted) — — -0,67 — -0,79
Gross Profit — — — — —
Operating Income -6,92 M -7,73 M -8,99 M -6,15 M -8,64 M
EBITDA — — — — —
R&D Expenses 2,65 M 2,31 M 3,06 M 1,74 M 1,59 M
SG&A Expenses — — — 4,41 M 7,04 M
D&A — — — — —
Interest Expense 8.000,0 38.000,0 14.000,0 — —
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,68 M 4,44 M 2,61 M 2,40 M 1,87 M
Total Liabilities 1,62 M 1,22 M 968.000,0 1,41 M 4,90 M
Shareholders' Equity 1,06 M 3,22 M 1,65 M -3,19 M -3,03 M
Total Debt — — — — —
Cash & Equivalents 1,35 M 2,49 M 432.000,0 — —
Current Assets 1,83 M 3,23 M 783.000,0 1,59 M 1,59 M
Current Liabilities 1,53 M 1,02 M 968.000,0 1,36 M 4,84 M